Sponsor pipeline

Centre hospitalier de l'Université de Montréal (CHUM) clinical trial pipeline

Get alerts when Centre hospitalier de l'Université de Montréal (CHUM)'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-25

What changed in the last 30 days

5 trials changed in the last 30 days: 1 stopped, 4 with notable changes, 0 with minor changes only.

  1. Stopped

    SUPPRESS-NSCLC · Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

    Trial terminated

    Also in this update: Final enrollment: 52 participants (planned 68); Primary completion date changed from estimate of Dec 1, 2026 to Jan 6, 2026

    Centre hospitalier de l'Université de Montréal (CHUM)Phase 2 NCT04405401 Registry history of NCT04405401 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-30 NCT07850557 Hypertrophic Scar Prosthetic Pressure in Burn Amputee Not Yet Recruiting

Active trials by phase

Phase 1
5
Phase 1/2
4
Phase 2
14
Phase 2/3
1
Phase 3
4
Phase 4
5
Not charted: 81 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 27

Get alerts when Centre hospitalier de l'Université de Montréal (CHUM)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free